Clinical Trial Update: Research of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain Tumours

View source ↗

Summary

This completed clinical trial investigated molecular and metabolic markers in oligodendrogliomas and compared them with other brain tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oligodendroglioma

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Oligodendrogliomas | Status: COMPLETED